BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 20678321)

  • 1. Correlation of pandemic (H1N1) 2009 viral load with disease severity and prolonged viral shedding in children.
    Li CC; Wang L; Eng HL; You HL; Chang LS; Tang KS; Lin YJ; Kuo HC; Lee IK; Liu JW; Huang EY; Yang KD
    Emerg Infect Dis; 2010 Aug; 16(8):1265-72. PubMed ID: 20678321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors promoting the prolonged shedding of the pandemic (H1N1) 2009 influenza virus in patients treated with oseltamivir for 5 days.
    Ryoo SM; Kim WY; Sohn CH; Seo DW; Oh BJ; Lee JH; Lee YS; Lim KS
    Influenza Other Respir Viruses; 2013 Sep; 7(5):833-7. PubMed ID: 23279949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection.
    Ling LM; Chow AL; Lye DC; Tan AS; Krishnan P; Cui L; Win NN; Chan M; Lim PL; Lee CC; Leo YS
    Clin Infect Dis; 2010 Apr; 50(7):963-9. PubMed ID: 20180701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral load in patients infected with pandemic H1N1 2009 influenza A virus.
    To KK; Chan KH; Li IW; Tsang TY; Tse H; Chan JF; Hung IF; Lai ST; Leung CW; Kwan YW; Lau YL; Ng TK; Cheng VC; Peiris JS; Yuen KY
    J Med Virol; 2010 Jan; 82(1):1-7. PubMed ID: 19950247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China.
    Yu H; Liao Q; Yuan Y; Zhou L; Xiang N; Huai Y; Guo X; Zheng Y; van Doorn HR; Farrar J; Gao Z; Feng Z; Wang Y; Yang W
    BMJ; 2010 Sep; 341():c4779. PubMed ID: 20876641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.
    Fry AM; Goswami D; Nahar K; Sharmin AT; Rahman M; Gubareva L; Azim T; Bresee J; Luby SP; Brooks WA
    Lancet Infect Dis; 2014 Feb; 14(2):109-18. PubMed ID: 24268590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China.
    Cao B; Li XW; Mao Y; Wang J; Lu HZ; Chen YS; Liang ZA; Liang L; Zhang SJ; Zhang B; Gu L; Lu LH; Wang DY; Wang C;
    N Engl J Med; 2009 Dec; 361(26):2507-17. PubMed ID: 20007555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed oseltamivir treatment is associated with longer viral shedding of pandemic (H1N1) 2009 virus.
    Leung YH; Lim WL; Wong MH; Chuang SK
    Epidemiol Infect; 2012 May; 140(5):814-7. PubMed ID: 21801465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural viral load profile of patients with pandemic 2009 influenza A(H1N1) and the effect of oseltamivir treatment.
    Li IW; Hung IF; To KK; Chan KH; Wong SS; Chan JF; Cheng VC; Tsang OT; Lai ST; Lau YL; Yuen KY
    Chest; 2010 Apr; 137(4):759-68. PubMed ID: 20061398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological and clinical features of 308 hospitalized patients with novel 2009 influenza A (H1N1) virus infection in China during the first pandemic wave.
    Zhang G; Xia Z; Liu Y; Li X; Tan X; Tian Y; Liang L; Nie G; Zhou B
    Intervirology; 2011; 54(3):164-70. PubMed ID: 21051903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children.
    Stephenson I; Democratis J; Lackenby A; McNally T; Smith J; Pareek M; Ellis J; Bermingham A; Nicholson K; Zambon M
    Clin Infect Dis; 2009 Feb; 48(4):389-96. PubMed ID: 19133796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of viral shedding in hospitalized patients infected with pandemic H1N1.
    Meschi S; Selleri M; Lalle E; Bordi L; Valli MB; Ferraro F; Ippolito G; Petrosillo N; Lauria FN; Capobianchi MR
    BMC Infect Dis; 2011 May; 11():140. PubMed ID: 21605362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of viral shedding of influenza A (H1N1) virus infection treated with oseltamivir and/or traditional Chinese medicine in China: a retrospective analysis.
    Wang YG; Jiang M; Wang RB; Zha QL; Zhang SJ; Zhou GQ; Li XW; Wang YY; Lv AP
    J Tradit Chin Med; 2012 Jun; 32(2):148-55. PubMed ID: 22876436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing occurrence and severity of pneumonia due to pandemic H1N1 2009 by early oseltamivir administration: a retrospective study in Mexico.
    Higuera Iglesias AL; Kudo K; Manabe T; Corcho Berdugo AE; Corrales Baeza A; Alfaro Ramos L; Guevara Gutiérrez R; Manjarrez Zavala ME; Takasaki J; Izumi S; Bautista E; Perez Padilla JR
    PLoS One; 2011; 6(7):e21838. PubMed ID: 21760915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of viral shedding in patients admitted to hospital with pandemic influenza A/H1N1 2009 infection.
    Na S; Chong YP; Kim MN; Kim WY; Kim W; Hong SB; Lim CM; Koh Y; Kwon JW; Hong SJ; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    J Med Virol; 2011 Jan; 83(1):5-9. PubMed ID: 21108333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pandemic influenza A(H1N1) 2009: molecular characterisation and duration of viral shedding in intensive care patients in Bordeaux, south-west France, May 2009 to January 2010.
    Malato L; Llavador V; Marmier E; Youssef J; Balick Weber C; Rozé H; Bessede E; Fleury HJ
    Euro Surveill; 2011 Jan; 16(4):. PubMed ID: 21284922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible recurrent pandemic (H1N1) 2009 infection, Israel.
    Kopel E; Mandelboim M; Amitai Z; Grotto I; Hindiyeh M; Kaliner E; Mendelson E; Volovik I
    Emerg Infect Dis; 2010 Aug; 16(8):1321-2. PubMed ID: 20678338
    [No Abstract]   [Full Text] [Related]  

  • 18. Persistence of pandemic influenza H1N1 virus in young patients after oseltamivir therapy in the 2009-2010 season: a comparison with seasonal H1N1 with or without H275Y mutation.
    Kawai N; Ikematsu H; Iwaki N; Kondou K; Hirotsu N; Kawashima T; Maeda T; Tanaka O; Doniwa K; Iwakuni O; Egashira K; Yamaji K; Kashiwagi S
    J Infect Chemother; 2012 Apr; 18(2):180-6. PubMed ID: 22193710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pandemic Influenza A (H1N1) 2009 in India: duration of virus shedding in patients under antiviral treatment.
    Gandhoke I; Rawat DS; Rai A; Khare S; Ichhpujani RL
    Indian J Med Microbiol; 2011; 29(1):37-41. PubMed ID: 21304193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between virus shedding and fever duration after treating children with pandemic A H1N1/09 and children with A H3N2 with a neuraminidase inhibitor.
    Sugaya N; Sakai-Tagawa Y; Bamba M; Yasuhara R; Yamazaki M; Kawakami C; Yamaguchi Y; Ide Y; Ichikawa M; Mitamura K; Kawaoka Y
    Antivir Ther; 2015; 20(1):49-55. PubMed ID: 24832015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.